XML 37 R19.htm IDEA: XBRL DOCUMENT
v3.25.1

SHARE BASED COMPENSATION | 12 Months Ended
--- | ---
Dec. 31, 2024
SHARE BASED COMPENSATION |
SHARE-BASED COMPENSATION | NOTE 10 – SHARE-BASED COMPENSATION For share-based awards granted, we have recognized compensation expense based on the estimated grant date fair value method. For these awards we have recognized compensation expense using a straight-line amortization method and reduced for estimated forfeitures. The impact on our results of operations of recording share-based compensation for the years ended December 31, 2024 and 2023 was as follows:
|  | Year Ended December 31, |
|  | 2024 |  |  | 2023 |
(in thousands) |  |  |  |  |  |
Cost of goods sold |  | $ | 112 |  |  | $ | 95 |
Research and development |  |  | 228 |  |  |  | 257 |
Selling, general and administrative |  |  | 636 |  |  |  | 838 |
Total share-based compensation |  | $ | 976 |  |  | $ | 1,190 |
An immaterial amount of share-based compensation was capitalized into inventory as overhead for the years ended December 31, 2024 and 2023, respectively. The following table summarizes stock option activity under our stock option plans for the twelve months ended December 31, 2024 and 2023:
|  | 2024 |  |  | 2023 |
|  | Options |  |  | Weighted-Average Exercise Price |  |  | Weighted-Average Remaining Contractual Life in Years |  |  | Options |  |  | Weighted-Average Exercise Price |  |  | Weighted-Average Remaining Contractual Life in Years |
Outstanding at beginning of year |  |  | 12,500 |  |  | $ | 4.98 |  |  |  |  |  |  | 12,500 |  |  | $ | 4.98 |  |  |  |
Granted |  |  | 200,000 |  |  | $ | 2.39 |  |  |  |  |  |  | - |  |  |  | - |  |  |  |
Exercised |  |  | - |  |  |  | - |  |  |  |  |  |  | - |  |  |  | - |  |  |  |
Cancelled, Expired or Forfeited |  |  | (12,500 | ) |  | $ | 4.98 |  |  |  |  |  |  | - |  |  |  | - |  |  |  |
Outstanding at end of year |  |  | 200,000 |  |  | $ | 2.39 |  |  |  | 5.67 |  |  |  | 12,500 |  |  | $ | 4.98 |  |  |  | 1.33 |
Vested or expected to vest at the end of the period |  |  | 182,676 |  |  | $ | 2.39 |  |  |  | 1.33 |  |  |  | 12,500 |  |  | $ | 4.98 |  |  |  | 1.33 |
Exercisable at end of year |  |  | 12,500 |  |  | $ | 2.39 |  |  |  | 1.33 |  |  |  | 12,500 |  |  | $ | 4.98 |  |  |  | 1.33 |
The aggregate intrinsic value of outstanding options is $81,540. There were no stock option awards exercised in 2024. Restricted stock award activity including performance-based stock award activity under our share-based compensation plan was as follows:
|  | 2024 |  |  | 2023 |
|  | Awards |  |  | Weighted - Average Grant Date Fair Value |  |  | Awards |  |  | Weighted - Average Grant Date Fair Value |
Outstanding at beginning of year |  |  | 728,625 |  |  | $ | 4.17 |  |  |  | 665,200 |  |  | $ | 3.94 |
Granted |  |  | 363,150 |  |  |  | 2.87 |  |  |  | 387,100 |  |  |  | 4.36 |
Vested |  |  | (296,209 | ) |  |  | 4.12 |  |  |  | (284,925 | ) |  |  | 3.93 |
Cancelled |  |  | (323,666 | ) |  |  | 3.66 |  |  |  | (38,750 | ) |  |  | 3.96 |
Outstanding at end of year |  |  | 471,900 |  |  | $ | 3.55 |  |  |  | 728,625 |  |  | $ | 4.17 |
During the years ended December 31, 2024 and 2023, 86,007 and 83,753 shares, respectively, were withheld from issuance related to restricted stock units vesting and stock option exercises to cover employee taxes and stock options exercise price. Non-employee directors Restricted Stock Units (“RSUs”) typically vest over the earlier of one year or the next annual meeting of shareholders and Non-Qualified stock options vest over three years and have a six-year exercise period. Employee RSUs typically vest annually over three or four years and employee Non-Qualified stock options typically vest quarterly over four years and have a six-year exercise period. Performance Stock Units (“PSUs”) typically cliff vest at the end of the performance period and the performance metric for 2023 awards is cumulative revenue growth over the three-year period ending December 31, 2025 with a cumulative revenue threshold, target, and maximum performance measure. For 2024 awards, the performance metrics included revenue growth, EBITDA and project objective targets over the three-year period ending December 31, 2026. The table above includes performance shares granted in 2024 of 124,000 shares at the target performance level (the threshold level would be 50% and the maximum level would be 150% of the target level). The remaining unamortized expected future compensation expense and remaining amortization period associated with unvested option grants and restricted stock awards are:
|  | December 31, 2024 |  |  | December 31, 2023 |
Unamortized future compensation expense |  | $ | 1,413,500 |  |  | $ | 2,317,524 |
Remaining weighted average amortization period in years |  |  | 2.31 |  |  |  | 2.44 |
The weighted average number of shares outstanding used to compute earnings (loss) per share included the following:
|  | Year Ended December 31, |
|  | 2024 |  |  | 2023 |
Weighted average shares outstanding |  |  | 9,149,538 |  |  |  | 8,940,612 |
Restricted and Performance Stock Units |  |  | - |  |  |  | 132,360 |
Stock Options |  |  | - |  |  |  | 216 |
Weighted average shares |  |  | 9,149,538 |  |  |  | 9,073,188 |

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration